(Q81459571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Kinetics of cell migration to the dermis and hypodermis in dogs vaccinated with antigenic compounds of Leishmania braziliensis plus saponin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

Leishmania braziliensis

1 reference

1 reference

Rodrigo Corrêa-Oliveira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Rodolfo C. Giunchetti

4

object named as

Rodolfo C Giunchetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Juliana Vitoriano-Souza

1

object named as

Juliana Vitoriano-Souza

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Alexandre B Reis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Nádia D Moreira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cláudia M Carneiro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

22 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

3922-3931

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

Leishmaniasis: current situation and new perspectives

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Analysis of the cytokine profile in spleen cells from dogs naturally infected by Leishmania chagasi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Chemotherapy of canine leishmaniosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Treatment of canine Old World visceral leishmaniasis: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Experimental models for leishmaniasis and for testing anti-leishmanial vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Vaccination against Leishmania infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Vaccine for prophylaxis and immunotherapy, Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

A new approach to the phylogeny of Leishmania: species specificity of glycoconjugate ligands for promastigote internalization into murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Cell mediated immunity and the inflammatory system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha, IL-beta, TNF alpha, IL-2 and Ifn gamma in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Peritoneal neutrophilia: a potential indicator of the surgical acute abdomen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Neutrophils and intracellular pathogens: beyond phagocytosis and killing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Neutrophils efficiently cross-prime naive T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

The neutrophil as a cellular source of chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

The role of CD8 T cells in innate immunity and in antigen non-specific protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Nitric oxide synthases: Roles, tolls, and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Nitric oxide and the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Cytokines and nitric oxide as effector molecules against parasitic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

The role of NO in contact hypersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

Immunology of leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.04.084

7 January 2021

inferred from DOI database lookup

Adjuvant effect of Quil-A on the porcine humoral immune response (author's transl)

1 reference

12 December 2020

Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise

1 reference

12 December 2020

Saponins as vaccine adjuvants

1 reference

12 December 2020

Regulation of biosynthesis of nitric oxide.

1 reference

12 December 2020

Experimental murine Leishmania donovani infection: immunoprotection by the fucose-mannose ligand (FML)

1 reference

12 December 2020

Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production.

1 reference

12 December 2020

Traces of bacterial lipopolysaccharide suppress IFN-gamma-induced nitric oxide synthase gene expression in primary mouse macrophages.

1 reference

12 December 2020

Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature

1 reference

12 December 2020

The regression of a canine Langerhans cell tumour is associated with increased expression of IL-2, TNF-alpha, IFN-gamma and iNOS mRNA

1 reference

12 December 2020

Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes

1 reference

12 December 2020

10.1016/J.VACCINE.2008.04.084

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18555567%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference